SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,007,142 | -18.1% | 580,600 | -10.7% | 0.26% | -7.5% |
Q2 2023 | $19,546,695 | +339.1% | 650,256 | +429.2% | 0.28% | +329.2% |
Q1 2023 | $4,451,979 | +12.4% | 122,881 | +10.7% | 0.06% | +22.6% |
Q4 2022 | $3,961,011 | -1.9% | 111,046 | -6.9% | 0.05% | -8.6% |
Q3 2022 | $4,038,000 | +69.5% | 119,278 | +44.8% | 0.06% | +70.6% |
Q2 2022 | $2,383,000 | +25.0% | 82,400 | +39.7% | 0.03% | +54.5% |
Q1 2022 | $1,907,000 | -80.8% | 59,000 | -89.3% | 0.02% | -88.6% |
Q1 2020 | $9,945,000 | -27.2% | 552,800 | -4.0% | 0.19% | -10.6% |
Q4 2019 | $13,653,000 | +19.3% | 575,600 | +38.2% | 0.22% | +1.4% |
Q3 2019 | $11,448,000 | -25.9% | 416,600 | -10.8% | 0.21% | -19.3% |
Q2 2019 | $15,453,000 | +51.5% | 467,000 | +60.5% | 0.26% | -52.9% |
Q1 2019 | $10,197,000 | -11.1% | 291,000 | -15.7% | 0.56% | -25.6% |
Q4 2018 | $11,464,000 | -41.1% | 345,100 | -10.7% | 0.75% | -38.9% |
Q3 2018 | $19,460,000 | -0.4% | 386,500 | +18.3% | 1.23% | -25.9% |
Q2 2018 | $19,547,000 | +47.8% | 326,600 | +13.1% | 1.67% | +27.2% |
Q1 2018 | $13,227,000 | +38.1% | 288,800 | +20.1% | 1.31% | +30.9% |
Q4 2017 | $9,580,000 | +186.7% | 240,400 | +46.6% | 1.00% | +59.1% |
Q2 2016 | $3,341,000 | -50.3% | 164,000 | -62.8% | 0.63% | -48.4% |
Q1 2016 | $6,725,000 | – | 441,000 | – | 1.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
S&T BANK/PA | 223,775 | $8,107 | 1.46% |
Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |